Skip to content

Clinical trials

Observational Acute Coronary Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Observational Country / region: China Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20111
20122
20131
20145
20153
20166
20177
20187
20199
20202
20214
20221
20235
20247
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status25
Recruiting10
Not yet recruiting4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital4
Qilu Hospital of Shandong University4
The First Affiliated Hospital of Dalian Medical University4
AstraZeneca3
Chinese Academy of Medical Sciences, Fuwai Hospital3
Chinese PLA General Hospital3
RenJi Hospital3
Beijing Institute of Heart, Lung and Blood Vessel Diseases2
Henan Institute of Cardiovascular Epidemiology2
Peking University First Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome66
Coronary Artery Disease6
Chest Pain4
Heart Failure3
Myocardial Infarction3
Angina, Stable2
Angina, Unstable2
Hemorrhage2
Myocardial Ischemia2
ST Elevation Myocardial Infarction2

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.